Skip to main content

GeneDx to Participate in 44th Annual Cowen Health Care Conference

STAMFORD, Conn., Feb. 26, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced that company management will participate in the Cowen Healthcare Conference from March 4-6 in Boston, MA. Management will participate in a fireside chat on Wednesday, March 6, 2024, at 10:30 a.m. ET.

A live and archived webcast of the presentation will be available on the “Events” section of the GeneDx investor relations website at ir.genedx.com/news-events/events.

About GeneDx
At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world’s largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It all starts with a single test. For more information, please visit www.genedx.com and connect with us on LinkedIn, Facebook, Twitter and Instagram.

GeneDx Investor Relations Contact: Investors@GeneDx.com

GeneDx Media Contact: Press@GeneDx.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  218.38
-3.65 (-1.64%)
AAPL  260.15
-2.62 (-1.00%)
AMD  232.15
-5.88 (-2.47%)
BAC  51.00
-0.52 (-1.01%)
GOOG  256.79
+5.45 (2.17%)
META  733.79
+0.52 (0.07%)
MSFT  523.60
+5.94 (1.15%)
NVDA  180.22
-0.94 (-0.52%)
ORCL  272.70
-2.45 (-0.89%)
TSLA  437.32
-5.28 (-1.19%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.